{{Rsnum
|rsid=2573905
|Gene=PCDH11X
|Chromosome=X
|position=92147221
|Orientation=plus
|GMAF=0.3881
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PCDH11X
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 36.9 | 18.5 | 44.6
| HCB | 4.4 | 6.7 | 88.9
| JPT | 4.5 | 11.4 | 84.1
| YRI | 69.8 | 14.3 | 15.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 6.7 | 88.9
| CHD | 7.5 | 5.7 | 86.8
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19136949
|Trait=Alzheimer's disease
|Title=Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease
|RiskAllele=
|Pval=2E-7
|OR=1.29
|ORtxt=[1.17-1.42]
|OA=1
}}

{{PharmGKB
|RSID=rs2573905
|Name_s=
|Gene_s=PCDH11X
|Feature=
|Evidence=PubMed ID:19136949; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. (Initial Sample Size: 844 cases, 1,255 controls; Replication Sample Size: 1,547 cases, 1,209 controls); (Region: Xq21.31; Reported Gene(s): PCDH11X; Risk Allele: rs2573905-?); (p-value= 0.0000002).This variant is associated with Alzheimer's disease.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740072
}}

{{PMID Auto
|PMID=20523261
|Title=PCDH11X variation is not associated with late-onset Alzheimer disease susceptibility
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2573905
|overall_frequency_n=41
|overall_frequency_d=92
|overall_frequency=0.445652
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=48
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}